Circulating Metabolites as Biomarkers of Disease in Patients with Mesial Temporal Lobe Epilepsy

A major challenge in the clinical management of patients with mesial temporal lobe epilepsy (MTLE) is identifying those who do not respond to antiseizure medication (ASM), allowing for the timely pursuit of alternative treatments such as epilepsy surgery. Here, we investigated changes in plasma meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Godoi, Alexandre B., do Canto, Amanda M., Donatti, Amanda, Rosa, Douglas C., Bruno, Danielle C. F., Alvim, Marina K., Yasuda, Clarissa L., Martins, Lucas G., Quintero, Melissa, Tasic, Ljubica, Cendes, Fernando, Lopes-Cendes, Iscia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148034/
https://www.ncbi.nlm.nih.gov/pubmed/35629950
http://dx.doi.org/10.3390/metabo12050446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148034/
https://www.ncbi.nlm.nih.gov/pubmed/35629950
http://dx.doi.org/10.3390/metabo12050446

Ejemplares similares